Tradjenta and Blood glucose abnormal - a phase IV clinical study of FDA data

Summary:

Blood glucose abnormal is reported as a side effect among people who take Tradjenta (linagliptin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Metformin, and have High blood pressure.

The phase IV clinical study analyzes which people have Blood glucose abnormal when taking Tradjenta. It is created by eHealthMe based on reports of 9,889 people who have side effects when taking Tradjenta from the FDA, and is updated regularly.

What is Tradjenta?

Tradjenta has active ingredients of linagliptin. It is often used in diabetes. eHealthMe is studying from 9,987 Tradjenta users. Check the latest studies of Tradjenta.

What is Blood glucose abnormal?

Blood glucose abnormal is found to be associated with 881 drugs and 812 conditions by eHealthMe. Check the latest studies of Blood glucose abnormal.

On Aug, 04, 2026

9,889 people reported to have side effects when taking Tradjenta.
Among them, 132 people (1.33%) have Blood glucose abnormal.

Could Tradjenta cause Blood glucose abnormal?

Among these 132 people:

How long have people been on Tradjenta when they have Blood glucose abnormal? *

Click here to view more results

What is the gender of people who have Blood glucose abnormal when taking Tradjenta? *

Click here to view

What is the age of people who have Blood glucose abnormal when taking Tradjenta? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Tradjenta and have Blood glucose abnormal?

- Check whether Blood glucose abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tradjenta:

Tradjenta (9,987 reports)

Blood glucose abnormal treatments and more:

Blood glucose abnormal (24,570 reports)

How severe was Blood glucose abnormal and when was it recovered:

Blood glucose abnormal in Tradjenta

Expand to all the drugs that have ingredients of linagliptin:

Blood glucose abnormal and drugs with ingredients of linagliptin (178 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tradjenta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blood glucose abnormal:

Blood glucose abnormal (881 drugs)

Browse all the conditions that are associated with Blood glucose abnormal:

Blood glucose abnormal (812 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on linagliptin (the active ingredients of Tradjenta) and Tradjenta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.